Physician profile
Todd C Peterson
NPI 1407085103
$13,852.82
in general payments reported to CMS, 2019-2025
11 companies · $451 in 2025
The $451 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,072 · 2020: $715 · 2021: $1,977 · 2022: $3,874 · 2023: $1,265 · 2024: $498 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,213.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,272.36 | 2019-2022 | |
| Wardlow Enterprises | $3,773.76 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $1,892.32 | 2019-2025 | Oxford, Persona, Tapestry |
| Smith+Nephew, INC. | $1,541.42 | 2019-2025 | Real Intelligence, Journey II, Pico 14 |
| Maxx Orthopedics, INC. | $1,325.74 | 2021-2024 | |
| Stryker Corporation | $493.89 | 2019-2022 | |
| Prism Medical | $320.98 | 2024-2025 | |
| Depuy Synthes Sales INC. | $108.64 | 2020-2024 | Na, Orthovisc, Monovisc |
| Maxx Health INC | $82.50 | 2023 | Summa Ortho Distal Radius |
| Heron Therapeutics, INC. | $20.69 | 2024 | Zynrelef |
| Davol INC. | $20.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.